We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Commentary |

Novel Technology for Locating Hidden Egyptian Tombs and Detailing Schlemm Canal Physiology

L. Jay Katz, MD1
[+] Author Affiliations
1Glaucoma Service, Wills Eye Hospital, Philadelphia, Pennsylvania
JAMA Ophthalmol. 2016;134(9):982. doi:10.1001/jamaophthalmol.2016.2015.
Text Size: A A A
Published online


Mysteries often are solved with the introduction of newer technology that reveals more information helping to answer lingering questions. Recently, for example, ground-penetrating radar using radiating electromagnetic pulses at the tomb of King Tutankhamun detected additional hidden rooms that may prove to be the long-lost burial chamber of Queen Nefertiti.1 Similarly, using enhanced depth imaging with anterior segment optical coherence tomography, Skaat et al2 have examined the effect of topical pilocarpine hydrochloride, a drug used to treat glaucoma for more than a century, on the structure of the Schlemm canal in healthy eyes and eyes with glaucoma. They were able to convincingly demonstrate in vivo that after a single drop of pilocarpine was administered, there was an increase in the cross-sectional area and volume of the Schlemm canal in healthy and glaucomatous eyes. Pilocarpine is a muscarinic agonist known to stimulate the ciliary muscle that pulls on the scleral spur and opens the trabecular meshwork. Skaat and colleagues suggest that pilocarpine may be having a direct effect on the Schlemm canal or an indirect effect through activation of the ciliary muscle or trabecular meshwork apparatus.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles